Exome Sequencing Study Implicates New Breast, Ovarian Cancer Susceptibility Genes

A team led by researchers at Ambry Genetics has conducted a large-scale exome sequencing study to confirm reported predisposition genes for breast and ovarian cancer, as well as identify new genetic mutations associated with these diseases.

Source: https://www.genomeweb.com/cancer/exome-sequencing-study-implicates-new-breast-ovarian-cancer-susceptibility-genes?utm_source=Sailthru&utm_medium=email&utm_campaign=GWDN%20Thurs%20PM%202018-08-16&utm_term=GW%20Daily%20News%20Bulletin